
MassBio Maps Rescue Plan for Life Science Startups
The free-flowing funding climate in biotech slowed to a trickle in 2022, choking off the supply of tenants to fill Boston’s explosion of new life science real estate.
The free-flowing funding climate in biotech slowed to a trickle in 2022, choking off the supply of tenants to fill Boston’s explosion of new life science real estate.
Despite the spring’s bad headlines, this summer ended with a pile of venture capital deals and two more Bay State biotech IPOs. It’s time for Beacon Hill to do its part to keep that momentum going.
A new report found that funding and employment in the financial technology sector in Massachusetts improved from 2020 to 2022. However, there is still room for improvement in diversity and inclusion, collaboration between industry stakeholders and partnership with regulators.
Venture capital investment in Greater Boston’s life science industry rose to its highest level in more than a year, as local companies scored six of the 10 largest deals nationwide during the second quarter.
A major source of funding for Massachusetts life science companies dropped sharply in 2022, but still exceeds pre-pandemic investment levels.
Boston-based financial technology firm Stavvy has raised $40 million in a funding round and partnered with a Michigan-based lender as the fintech continues to build digital banking and lending platforms.
Fenway-based fitness wearables company Whoop has signed the first office lease at Related Beal’s One Kenmore Square development as its new corporate headquarters and home base for approximately 1,000 employees.
Boston-based financial technology firm FiVerity Inc. has raised $2 million to expand its cyber fraud detection and threat intelligence platform for banks, credit unions and credit card providers.
A Boston-based startup that provides tenant experience software and apps to large commercial landlords has received $34.25 million in series B venture funding led by Insight Partners.